Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001040197-24-000005·MAI Capital Management
Schedule 13G ownership disclosure
Trevi Therapeutics Inc
Common Shares · CUSIP: 89532M101
Event date: 2022-05-12
- Filing-level shares
- 1,519,650.00
- Percent of class
- 2.2%
- MAI Capital Management
Shares: 1,519,650.00 · Class: 2.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001040197-24-000005
- Form type
- SCHEDULE 13G/A
- Filer
- MAI Capital Management
- CIK
- CIK 1040197
- Filed
- Jul 10, 2024
- Reporting period
- May 12, 2022
- Description
- Schedule 13G beneficial ownership